Tanke Biosciences Corp income statement TNBI

Annual Quarterly

In Q3 of fiscal 2013, the quarter ended Sep 30, 2013, Tanke Biosciences Corp reported revenue of $6.0 million, down 39.0% from the same quarter a year earlier. It recorded a net loss of $302,084. The operating loss came to $530,338, an operating margin of -8.8%.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2013	Q3 FY2013 Sep 30, 2013	Q2 FY2013 Jun 30, 2013	Q1 FY2013 Mar 31, 2013	Q4 FY2012 Dec 31, 2012	Q3 FY2012 Sep 30, 2012	Q2 FY2012 Jun 30, 2012	Q1 FY2012 Mar 31, 2012	Q4 FY2011 Dec 31, 2011
Revenue	23 -19.5%	6 -39.0%	6 -25.0%	5 +2.6%	7 +0.4%	10 +58.6%	7 +48.9%	5	7
Cost of revenue	16 -15.9%	4 -33.3%	4 -20.0%	3 +1.4%	4 +2.9%	7 +62.9%	5 +45.8%	3	4
Gross profit	7 -26.2%	2 -50.0%	2 -33.5%	2 +4.9%	2 -4.1%	3 +50.9%	3 +54.7%	2	2
Research and development	—	—	—	—	0	0	—	—	—
Selling, general and administrative	7 +46.5%	2 +81.7%	2 +31.9%	2 +51.0%	2 +25.9%	1 +15.0%	1 -12.2%	1	1
Operating income	-0 -101.1%	-1 -124.3%	0 -90.0%	-0 -108.2%	0 -64.4%	2 +81.3%	1 +552.2%	0	1
Interest income	0 +6.2%	0 +523.8%	0 -87.3%	0 -65.4%	0 +53.8%	0 -7.8%	0 +6578.0%	0	0
Interest expense	1 -35.5%	-0 -114.7%	0 -89.3%	0 -42.4%	0 +385.6%	0 -61.1%	0 -12.9%	0	-0
Other non-operating income (expense)	—	-0	0	0	—	—	—	—	—
Pretax income	-1 -142.4%	-0 -128.5%	0 -71.1%	-1 -16.7%	-1 -128.7%	1 +194.5%	1 +137.9%	-1	2
Income tax	0 -71.3%	-0 -112.1%	0 -82.9%	0 -72.5%	0 +1.7%	0 +20.1%	0 +193.1%	0	0
Net income	-2 -164.1%	-0 -131.2%	0 -56.6%	-1 -0.8%	-1 -139.2%	1 +167.0%	0 +116.5%	-1	2
Basic EPS	—	—	—	—	—	0.07 +163.6%	0.02 +116.7%	-0.05	0.14
Diluted EPS	—	—	—	—	—	0.07 +163.6%	0.02 +116.7%	-0.05	0.15
Weighted average shares, basic	—	—	—	—	—	13 +0.0%	13 +0.0%	13	14
Weighted average shares, diluted	—	—	—	—	—	13 +0.0%	13 +0.0%	13	14
Other measures
Depreciation and amortization	1 +27.0%	0 +52.3%	0 +71.0%	0 +45.3%	0 -15.4%	0 +155.8%	0 +91.1%	0	0
EBITDA	1 -86.3%	-0 -112.3%	0 -78.0%	0 -77.1%	1 -54.0%	2 +85.0%	2 +452.7%	1	1
Interest coverage	-0.10x	—	3.80x	-0.19x	0.94x	6.90x	4.06x	1.31x	—
Margins
Gross margin	32.28%	28.00%	32.68%	35.75%	33.39%	34.17%	36.88%	34.96%	34.99%
Operating margin	-0.25%	-8.78%	2.68%	-0.86%	5.44%	22.03%	20.15%	10.76%	15.34%
Pretax margin	-6.26%	-5.63%	3.03%	-13.88%	-9.28%	12.02%	7.88%	-12.21%	32.52%
Profit margin	-7.15%	-5.00%	2.12%	-14.52%	-11.68%	9.78%	3.67%	-14.78%	29.88%
EBITDA margin	3.50%	-4.76%	6.39%	3.00%	8.91%	23.64%	21.77%	13.49%	19.46%
Effective tax rate	—	—	31.63%	—	—	18.68%	53.51%	—	8.12%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Grain Mill Products (SIC 2040)
Listed as: TNBI (OTC)
Fiscal year ends: December 31
Incorporated in: NV
Headquarters: Pearl River New City Guangzhou, China
SEC CIK: 1452011
Former names: GREYHOUND COMMISSARY, INC. (until Feb 3, 2011)

Other Grain Mill Products companies

All 6 Grain Mill Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.